Phase 2 Prostate Cancer Patients Clinical Trials
5 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–5 of 5 trials
Recruiting
Phase 2
A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
Prostate Cancer (Adenocarcinoma)Prostate Cancer Patients Treated by Radiotherapy
Candel Therapeutics, Inc.45 enrolled7 locationsNCT07332000
Recruiting
Phase 2
Hypofractionated Radiotherapy With a Focal Microboost for High-Risk and Locally Advanced Prostate Cancer
Prostate CancerProstate Cancer Patients Treated by Radiotherapy
Medical University of South Carolina46 enrolled1 locationNCT07325721
Recruiting
Phase 2Phase 3
A Randomised Trial of Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin (CDMS) Plus Surgery for Prostate Cancer Patients
Prostate Cancer Patients
Shanghai Jiao Tong University School of Medicine300 enrolled2 locationsNCT03258320
Recruiting
Phase 2
FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer
Prostate CancerProstate CancersProstate Cancer (Adenocarcinoma)+4 more
Cellvax Therapeutics Inc100 enrolled3 locationsNCT06636682
Recruiting
Phase 2
Intratumoral and Systemic Hiltonol® (Poly-ICLC) in Prostate Cancer Patients on Active Surveillance
Prostate Cancer Patients on Active Surveillance
Ashutosh Kumar Tewari114 enrolled1 locationNCT06343077